Market Place
Sourcing Support
All News #Library
Biotech
Rezolute Applauds FDA Support For Hypoglycemia Drug Path
24 Mar 2026 //
BIOSPACE
Rezolute To Join Guggenheim Biotech Summit 2026
04 Feb 2026 //
GLOBENEWSWIRE
Rezolute Joins BTIG Virtual Biotechnology Conference
22 Jul 2025 //
GLOBENEWSWIRE
Rezolute Gets Positive Review in Ph3 Hyperinsulinism Study
23 Apr 2025 //
GLOBENEWSWIRE
Rezolute Updates on Ph 3 Study of Ersodetug for Hypoglycemia
04 Feb 2025 //
GLOBENEWSWIRE
Rezolute to Participate in Guggenheim SMID Cap Biotech Conference
31 Jan 2025 //
GLOBENEWSWIRE
Rezolute Gets FDA Breakthrough For Ersodetug In Hyperinsulinism
07 Jan 2025 //
GLOBENEWSWIRE
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
31 Jul 2024 //
GLOBENEWSWIRE
Rezolute Initiates Phase 3 Study for RZ358 in Congenital Hyperinsulinism
14 Dec 2023 //
GLOBENEWSWIRE
Rezolute Announces Further Evidence of RZ358™s Efficacy in Hyperinsulinism
11 Oct 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.